Allogene Therapeutics Inc (ALLO)
2.09
+0.14
(+7.18%)
USD |
NASDAQ |
Dec 24, 16:00
Allogene Therapeutics Total Assets (Quarterly): 589.12M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 1.287B |
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 125.37M |
| Shareholders Equity (Quarterly) | 463.75M |